Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CLINICALLY ISOLATED SYNDROME, . Treffer: 54

2023

Hegen, H; Arrambide, G; Gnanapavan, S; Kaplan, B; Khalil, M; Saadeh, R; Teunissen, C; Tumani, H; Villar, LM; Willrich, MAV; Zetterberg, H; Deisenhammer, F Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
Mult Scler. 2023; 29(2):182-195 Doi: 10.1177/13524585221134217 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hegen, H; Walde, J; Berek, K; Arrambide, G; Gnanapavan, S; Kaplan, B; Khalil, M; Saadeh, R; Teunissen, C; Tumani, H; Villar, LM; Willrich, MAV; Zetterberg, H; Deisenhammer, F Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
Mult Scler. 2022; 13524585221134213 Doi: 10.1177/13524585221134213 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Filippi, M; Preziosa, P; Meani, A; Dalla, Costa, G; Mesaros, S; Drulovic, J; Ivanovic, J; Rovira, A; Tintorè, M; Montalban, X; Ciccarelli, O; Brownlee, W; Miszkiel, K; Enzinger, C; Khalil, M; Barkhof, F; Strijbis, EMM; Frederiksen, JL; Cramer, SP; Fainardi, E; Amato, MP; Gasperini, C; Ruggieri, S; Martinelli, V; Comi, G; Rocca, MA, , MAGNIMS, Study, Group Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.
Neurology. 2022; 98(1):e1-e14 Doi: 10.1212/WNL.0000000000013016
Web of Science PubMed FullText FullText_MUG

 

Magyar, M; Gattringer, T; Enzinger, C; Hassler, E; Partl, R; Khalil, M; Reishofer, G; Deutschmann, H; Fazekas, F Incidence of Developmental Venous Anomalies in Patients With Multiple Sclerosis: A 3 Tesla MRI Study.
Front Neurol. 2022; 13: 824347 Doi: 10.3389/fneur.2022.824347 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Meaton, I; Altokhis, A; Allen, CM; Clarke, MA; Sinnecker, T; Meier, D; Enzinger, C; Calabrese, M; De, Stefano, N; Pitiot, A; Giorgio, A; Schoonheim, MM; Paul, F; Pawlak, MA; Schmidt, R; Granziera, C; Kappos, L; Montalban, X; Rovira, À; Wuerfel, J; Evangelou, N Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
Mult Scler. 2022; 28(14):2212-2220 Doi: 10.1177/13524585221118677 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pareto, D; Garcia-Vidal, A; Groppa, S; Gonzalez-Escamilla, G; Rocca, M; Filippi, M; Enzinger, C; Khalil, M; Llufriu, S; Tintoré, M; Sastre-Garriga, J; Rovira, À Prognosis of a second clinical event from baseline MRI in patients with a CIS: a multicenter study using a machine learning approach.
Neuroradiology. 2022; 64(7):1383-1390 Doi: 10.1007/s00234-021-02885-7
Web of Science PubMed FullText FullText_MUG

 

Pirpamer, L; Kincses, B; Kincses, ZT; Kiss, C; Damulina, A; Khalil, M; Stollberger, R; Schmidt, R; Enzinger, C; Ropele, S Periventricular magnetisation transfer abnormalities in early multiple sclerosis.
Neuroimage Clin. 2022; 34: 103012 Doi: 10.1016/j.nicl.2022.103012 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Voortman, MM; Damulina, A; Pirpamer, L; Pinter, D; Pichler, A; Enzinger, C; Ropele, S; Bachmaier, G; Archelos, JJ; Marsche, G; Khalil, M Decreased Cerebrospinal Fluid Antioxidative Capacity Is Related to Disease Severity and Progression in Early Multiple Sclerosis.
Biomolecules. 2021; 11(9): Doi: 10.3390/biom11091264 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Cole, JH; Raffel, J; Friede, T; Eshaghi, A; Brownlee, WJ; Chard, D; De Stefano, N; Enzinger, C; Pirpamer, L; Filippi, M; Gasperini, C; Rocca, MA; Rovira, A; Ruggieri, S; Sastre-Garriga, J; Stromillo, ML; Uitdehaag, BMJ; Vrenken, H; Barkhof, F; Nicholas, R; Ciccarelli, O; MAGNIMS study group Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm.
Ann Neurol. 2020; 88(1):93-105 Doi: 10.1002/ana.25746 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Leurs, CE; Twaalfhoven, H; Lissenberg-Witte, BI; van, Pesch, V; Dujmovic, I; Drulovic, J; Castellazzi, M; Bellini, T; Pugliatti, M; Kuhle, J; Villar, LM; Alvarez-Cermeño, JC; Alvarez-Lafuente, R; Hegen, H; Deisenhammer, F; Walchhofer, LM; Thouvenot, E; Comabella, M; Montalban, X; Vécsei, L; Rajda, C; Galimberti, D; Scarpini, E; Altintas, A; Rejdak, K; Frederiksen, JL; Pihl-Jensen, G; Jensen, P; Khalil, M; Voortman, MM; Fazekas, F; Saiz, A; La, Puma, D; Vercammen, M; Vanopdenbosch, L; Uitdehaag, B; Killestein, J; Bridel, C; Teunissen, C Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
Mult Scler. 2020; 26(8):912-923 Doi: 10.1177/1352458519845844 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Chatterjee, M; Koel-Simmelink, MJ; Verberk, IM; Killestein, J; Vrenken, H; Enzinger, C; Ropele, S; Fazekas, F; Khalil, M; Teunissen, CE Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis.
Mult Scler J Exp Transl Clin. 2019; 4(4):2055217318819535-2055217318819535 Doi: 10.1177/2055217318819535 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Fissolo, N; Cervera-Carles, L; Villar Guimerans, LM; Lleó, A; Clarimón, J; Drulovic, J; Dujmovic, I; Voortman, M; Khalil, M; Gil, E; Navarro, L; Álvarez-Cermeño, JC; Montalban, X; Comabella, M Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.
Mult Scler. 2019; 25(11):1535-1538 Doi: 10.1177/1352458518786055
Web of Science PubMed FullText FullText_MUG

 

Hagens, MH; Burggraaff, J; Kilsdonk, ID; Ruggieri, S; Collorone, S; Cortese, R; Cawley, N; Sbardella, E; Andelova, M; Amann, M; Lieb, JM; Pantano, P; Lissenberg-Witte, BI; Killestein, J; Oreja-Guevara, C; Wuerfel, J; Ciccarelli, O; Gasperini, C; Lukas, C; Rovira, A; Barkhof, F; Wattjes, MP; MAGNIMS Study Group Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study.
Mult Scler. 2019; 25(3):352-360 Doi: 10.1177/1352458517751647 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Bachmaier, G; Enzinger, C; Fazekas, F The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis.
Mult Scler. 2019; 25(1):48-54 Doi: 10.1177/1352458517736149
Web of Science PubMed FullText FullText_MUG

 

Sinnecker, T; Clarke, MA; Meier, D; Enzinger, C; Calabrese, M; De Stefano, N; Pitiot, A; Giorgio, A; Schoonheim, MM; Paul, F; Pawlak, MA; Schmidt, R; Kappos, L; Montalban, X; Rovira, À; Evangelou, N; Wuerfel, J; MAGNIMS Study Group Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.
JAMA Neurol. 2019; 130(11): Doi: 10.1001/jamaneurol.2019.2478 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Wottschel, V; Chard, DT; Enzinger, C; Filippi, M; Frederiksen, JL; Gasperini, C; Giorgio, A; Rocca, MA; Rovira, A; De Stefano, N; Tintoré, M; Alexander, DC; Barkhof, F; Ciccarelli, O; MAGNIMS study group and the EuroPOND consortium SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis.
Neuroimage Clin. 2019; 24: 102011-102011. Doi: 10.1016/j.nicl.2019.102011 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Eshaghi, A; Marinescu, RV; Young, AL; Firth, NC; Prados, F; Jorge Cardoso, M; Tur, C; De Angelis, F; Cawley, N; Brownlee, WJ; De Stefano, N; Laura Stromillo, M; Battaglini, M; Ruggieri, S; Gasperini, C; Filippi, M; Rocca, MA; Rovira, A; Sastre-Garriga, J; Geurts, JJG; Vrenken, H; Wottschel, V; Leurs, CE; Uitdehaag, B; Pirpamer, L; Enzinger, C; Ourselin, S; Gandini Wheeler-Kingshott, CA; Chard, D; Thompson, AJ; Barkhof, F; Alexander, DC; Ciccarelli, O Progression of regional grey matter atrophy in multiple sclerosis.
Brain. 2018; 141(6):1665-1677 Doi: 10.1093/brain/awy088 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Eshaghi, A; Prados, F; Brownlee, WJ; Altmann, DR; Tur, C; Cardoso, MJ; De Angelis, F; van de Pavert, SH; Cawley, N; De Stefano, N; Stromillo, ML; Battaglini, M; Ruggieri, S; Gasperini, C; Filippi, M; Rocca, MA; Rovira, A; Sastre-Garriga, J; Vrenken, H; Leurs, CE; Killestein, J; Pirpamer, L; Enzinger, C; Ourselin, S; Wheeler-Kingshott, CAMG; Chard, D; Thompson, AJ; Alexander, DC; Barkhof, F; Ciccarelli, O; MAGNIMS study group Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Ann Neurol. 2018; 83(2):210-222 Doi: 10.1002/ana.25145 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Filippi, M; Preziosa, P; Meani, A; Ciccarelli, O; Mesaros, S; Rovira, A; Frederiksen, J; Enzinger, C; Barkhof, F; Gasperini, C; Brownlee, W; Drulovic, J; Montalban, X; Cramer, SP; Pichler, A; Hagens, M; Ruggieri, S; Martinelli, V; Miszkiel, K; Tintore, M; Comi, G; Dekker, I; Uitdehaag, B; Dujmovic-Basuroski, I; Rocca, MA Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study
LANCET NEUROL. 2018; 17(2): 133-142. Doi: 10.1016/S1474-4422(17)30469-6
Web of Science PubMed FullText FullText_MUG

 

Thompson, AJ; Banwell, BL; Barkhof, F; Carroll, WM; Coetzee, T; Comi, G; Correale, J; Fazekas, F; Filippi, M; Freedman, MS; Fujihara, K; Galetta, SL; Hartung, HP; Kappos, L; Lublin, FD; Marrie, RA; Miller, AE; Miller, DH; Montalban, X; Mowry, EM; Sorensen, PS; Tintoré, M; Traboulsee, AL; Trojano, M; Uitdehaag, BMJ; Vukusic, S; Waubant, E; Weinshenker, BG; Reingold, SC; Cohen, JA Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Lancet Neurol. 2018; 17(2):162-173 Doi: 10.1016/S1474-4422(17)30470-2
Web of Science PubMed FullText FullText_MUG

 

Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Mult Scler J Exp Transl Clin. 2018; 4(3):2055217318800810-2055217318800810 Doi: 10.1177/2055217318800810 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

2017

Hennes, EM; Baumann, M; Schanda, K; Anlar, B; Bajer-Kornek, B; Blaschek, A; Brantner-Inthaler, S; Diepold, K; Eisenkölbl, A; Gotwald, T; Kuchukhidze, G; Gruber-Sedlmayr, U; Häusler, M; Höftberger, R; Karenfort, M; Klein, A; Koch, J; Kraus, V; Lechner, C; Leiz, S; Leypoldt, F; Mader, S; Marquard, K; Poggenburg, I; Pohl, D; Pritsch, M; Raucherzauner, M; Schimmel, M; Thiels, C; Tibussek, D; Vieker, S; Zeches, C; Berger, T; Reindl, M; Rostásy, K; BIOMARKER Study Group Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
Neurology. 2017; 89(9):900-908 Doi: 10.1212/WNL.0000000000004312 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Moser, AM; Spindelboeck, W; Strohmaier, H; Enzinger, C; Gattringer, T; Fuchs, S; Fazekas, F; Gorkiewicz, G; Wurm, P; Högenauer, C; Khalil, M Mucosal biopsy shows immunologic changes of the colon in patients with early MS.
Neurol Neuroimmunol Neuroinflamm. 2017; 4(4):e362-e362 Doi: 10.1212/NXI.0000000000000362 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Voortman, MM; Pekar, T; Bachmayer, D; Archelos, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis.
Mult Scler J Exp Transl Clin. 2017; 3(3):2055217317727294-2055217317727294 Doi: 10.1177/2055217317727294 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Voortman, MM; Stojakovic, T; Pirpamer, L; Jehna, M; Langkammer, C; Scharnagl, H; Reindl, M; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
Mult Scler. 2017; 23(11):1496-1505 Doi: 10.1177/1352458516681503 [Oral Communication]
Web of Science PubMed FullText FullText_MUG

 

2016

Hegen, H; Adrianto, I; Lessard, CJ; Millonig, A; Bertolotto, A; Comabella, M; Giovannoni, G; Guger, M; Hoelzl, M; Khalil, M; Fazekas, F; Killestein, J; Lindberg, RL; Malucchi, S; Mehling, M; Montalban, X; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Deisenhammer, F; Steinman, L; Axtell, RC Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients.
Neurol Neuroimmunol Neuroinflamm. 2016; 3(2):e202-e202 Doi: 10.1212/NXI.0000000000000202 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Pichler, A; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.
Mult Scler. 2016; 22(12):1560-1568 Doi: 10.1177/1352458515624560
Web of Science PubMed FullText FullText_MUG

 

2015

Cantó, E; Tintoré, M; Villar, LM; Costa, C; Nurtdinov, R; Álvarez-Cermeño, JC; Arrambide, G; Reverter, F; Deisenhammer, F; Hegen, H; Khademi, M; Olsson, T; Tumani, H; Rodríguez-Martín, E; Piehl, F; Bartos, A; Zimova, D; Kotoucova, J; Kuhle, J; Kappos, L; García-Merino, JA; Sánchez, AJ; Saiz, A; Blanco, Y; Hintzen, R; Jafari, N; Brassat, D; Lauda, F; Roesler, R; Rejdak, K; Papuc, E; de Andrés, C; Rauch, S; Khalil, M; Enzinger, C; Galimberti, D; Scarpini, E; Teunissen, C; Sánchez, A; Rovira, A; Montalban, X; Comabella, M Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Brain. 2015; 138(Pt 4):918-931 Doi: 10.1093/brain/awv017 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jehna, M; Pirpamer, L; Khalil, M; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Deutschmann, H; Fazekas, F; Enzinger, C Periventricular lesions correlate with cortical thinning in multiple sclerosis.
Ann Neurol. 2015; 78(4): 530-539. Doi: 10.1002/ana.24461
Web of Science PubMed FullText FullText_MUG

 

Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Gattringer, T; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.
Neurology. 2015; 84(24): 2396-2402. Doi: 10.1212/WNL.0000000000001679
Web of Science PubMed FullText FullText_MUG

 

Kuhle, J; Disanto, G; Dobson, R; Adiutori, R; Bianchi, L; Topping, J; Bestwick, JP; Meier, UC; Marta, M; Dalla Costa, G; Runia, T; Evdoshenko, E; Lazareva, N; Thouvenot, E; Iaffaldano, P; Direnzo, V; Khademi, M; Piehl, F; Comabella, M; Sombekke, M; Killestein, J; Hegen, H; Rauch, S; D'Alfonso, S; Alvarez-Cermeño, JC; Kleinová, P; Horáková, D; Roesler, R; Lauda, F; Llufriu, S; Avsar, T; Uygunoglu, U; Altintas, A; Saip, S; Menge, T; Rajda, C; Bergamaschi, R; Moll, N; Khalil, M; Marignier, R; Dujmovic, I; Larsson, H; Malmestrom, C; Scarpini, E; Fenoglio, C; Wergeland, S; Laroni, A; Annibali, V; Romano, S; Martínez, AD; Carra, A; Salvetti, M; Uccelli, A; Torkildsen, Ø; Myhr, KM; Galimberti, D; Rejdak, K; Lycke, J; Frederiksen, JL; Drulovic, J; Confavreux, C; Brassat, D; Enzinger, C; Fuchs, S; Bosca, I; Pelletier, J; Picard, C; Colombo, E; Franciotta, D; Derfuss, T; Lindberg, R; Yaldizli, Ö; Vécsei, L; Kieseier, BC; Hartung, HP; Villoslada, P; Siva, A; Saiz, A; Tumani, H; Havrdová, E; Villar, LM; Leone, M; Barizzone, N; Deisenhammer, F; Teunissen, C; Montalban, X; Tintoré, M; Olsson, T; Trojano, M; Lehmann, S; Castelnovo, G; Lapin, S; Hintzen, R; Kappos, L; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, SV; Giovannoni, G Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Mult Scler. 2015; 21(8):1013-1024 Doi: 10.1177/1352458514568827
Web of Science PubMed FullText FullText_MUG

 

Pinter, D; Khalil, M; Pichler, A; Langkammer, C; Ropele, S; Marschik, PB; Fuchs, S; Fazekas, F; Enzinger, C Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.
Neuroimage Clin. 2015; 7(4):715-720 Doi: 10.1016/j.nicl.2015.02.023 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Varosanec, M; Uher, T; Horakova, D; Hagemeier, J; Bergsland, N; Tyblova, M; Seidl, Z; Vaneckova, M; Krasensky, J; Dwyer, MG; Havrdova, E; Zivadinov, R Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome.
AJNR Am J Neuroradiol. 2015; 36(8):1457-1464 Doi: 10.3174/ajnr.A4330
Web of Science PubMed FullText FullText_MUG

 

2014

Hegen, H; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Polman, CH; Rudzki, D; Schautzer, F; Sellebjerg, F; Sørensen, PS; Deisenhammer, F Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
Mult Scler. 2014; 20(5):577-587 Doi: 10.1177/1352458513503597
Web of Science PubMed FullText FullText_MUG

 

Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis.
Mult Scler. 2014; 20(12):1569-1577 Doi: 10.1177/1352458514530020
Web of Science PubMed FullText FullText_MUG

 

Mitjana, R; Tintoré, M; Rocca, MA; Auger, C; Barkhof, F; Filippi, M; Polman, C; Fazekas, F; Huerga, E; Montalban, X; Rovira, A Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes.
Mult Scler. 2014; 20(11):1471-1477 Doi: 10.1177/1352458514526083
Web of Science PubMed FullText FullText_MUG

 

2013

Comi, G; Martinelli, V; Rodegher, M; Moiola, L; Leocani, L; Bajenaru, O; Carra, A; Elovaara, I; Fazekas, F; Hartung, HP; Hillert, J; King, J; Komoly, S; Lubetzki, C; Montalban, X; Myhr, KM; Preziosa, P; Ravnborg, M; Rieckmann, P; Rocca, MA; Wynn, D; Young, C; Filippi, M Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
Mult Scler. 2013; 19(8):1074-1083 Doi: 10.1177/1352458512469695 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fazekas, C; Khalil, M; Enzinger, C; Matzer, F; Fuchs, S; Fazekas, F No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
Clin Neurol Neurosurg. 2013; 115(3):293-297 Doi: 10.1016/j.clineuro.2012.05.022
Web of Science PubMed FullText FullText_MUG

 

Langkammer, C; Liu, T; Khalil, M; Enzinger, C; Jehna, M; Fuchs, S; Fazekas, F; Wang, Y; Ropele, S Quantitative susceptibility mapping in multiple sclerosis.
Radiology. 2013; 267(2):551-559 Doi: 10.1148/radiol.12120707 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Teunissen, CE; Khalil, M Neurofilaments as biomarkers in multiple sclerosis.
Mult Scler. 2012; 18(5):552-556 Doi: 10.1177/1352458512443092 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Bachmaier, G; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome.
Mult Scler. 2011; 17(2): 173-180. Doi: 10.1177/1352458510384009
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Mader, S; Gredler, V; Schanda, K; Rostasy, K; Dujmovic, I; Pfaller, K; Lutterotti, A; Jarius, S; Di Pauli, F; Kuenz, B; Ehling, R; Hegen, H; Deisenhammer, F; Aboul-Enein, F; Storch, MK; Koson, P; Drulovic, J; Kristoferitsch, W; Berger, T; Reindl, M Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
J Neuroinflammation. 2011; 8(7):184-184 Doi: 10.1186/1742-2094-8-184 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2010

Fazekas, F; Baumhackl, U; Berger, T; Deisenhammer, F; Fuchs, S; Kristoferitsch, W; Ladurner, G; Soukop, W; Wimmer, G; Vass, K Decision-making for and impact of early immunomodulatory treatment: the Austrian Clinically Isolated Syndrome Study (ACISS)
EUR J NEUROLOGY. 2010; 17(6): 852-860. Doi: 10.1111/j.1468-1331.2009.02943.x
Web of Science FullText FullText_MUG

 

Mader, S; Lutterotti, A; Di Pauli, F; Kuenz, B; Schanda, K; Aboul-Enein, F; Khalil, M; Storch, MK; Jarius, S; Kristoferitsch, W; Berger, T; Reindl, M Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
PLOS ONE. 2010; 5(5): e10455-e10455. Doi: 10.1371/journal.pone.0010455 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2009

Comi, G; Martinelli, V; Rodegher, M; Moiola, L; Bajenaru, O; Carra, A; Elovaara, I; Fazekas, F; Hartung, HP; Hillert, J; King, J; Komoly, S; Lubetzki, C; Montalban, X; Myhr, KM; Ravnborg, M; Rieckmann, P; Wynn, D; Young, C; Filippi, M Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial.
Lancet. 2009; 374(9700):1503-1511 Doi: 10.1016/S0140-6736(09)61259-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Korteweg, T; Tintore, M; Uitdehaag, BM; Knol, DL; Vrenken, H; Rovira, A; Frederiksen, J; Miller, DH; Fernando, K; Filippi, M; Agosta, F; Rocca, MA; Fazekas, F; Enzinger, C; Parry, A; Polman, CH; Montalban, X; Barkhof, F A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome.
Eur Radiol. 2009; 19(9): 2244-2248. Doi: 10.1007/s00330-009-1402-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2007

Fazekas, F; Strasser-Fuchs, S; Hommes, OR Intravenous immunoglobulin in MS: promise or failure?
J Neurol Sci. 2007; 259(1-2):61-66 Doi: 10.1016/j.jns.2006.12.018
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Bassetti, C; Beer, K; Beer, S; Buettner, U; Chofflon, M; Gass, A; Goebels, N; Gotschi-Fuchs, M; Kappos, L; Kesselring, J; Ludin, HP; Mattle, H; Schluep, M; Vaney, C; Baumhackl, U; Berger, T; Deisenhammer, F; Fazekas, F; Freimuller, M; Kollegger, H; Kristoferitsch, W; Lassmann, H; Markut, H; Strasser-Fuchs, S; Vass, K; Altenkirch, H; Bamborschke, S; Baum, K; Bayas, A; Benecke, R; Bruck, W; Buttmann, M; Chan, A; Daumer, M; Dommasch, D; Elias, WG; Fasshauer, E; Flachenecker, P; Gehlen, W; Gold, R; Haas, J; Haferkamp, G; Haller, P; Hartung, HP; Heesen, C; Heibel, M; Heidenreich, F; Hemmer, B; Henze, T; Hohlfeld, R; Janzen, RWC; Japp, G; Jung, S; Jugelt, E; Kallmann, B; Kieseier, BC; Kleinschnitz, C; Kohler, J; Kohler, W; Kolmel, W; Konig, N; Lehrieder, G; Leussink, V; Lowitzsch, K; Maurer, M; Manegold, U; Melms, A; Mertin, J; Neuhaus, O; Oschmann, P; Petereit, HF; Pette, M; Pohlau, D; Pohl, D; Rieckmann, P; Ruprecht, K; Sailer, M; Schipper, H; Schmidt, S; Schock, G; Schulz, M; Schwarz, S; Schwendemann, G; Seidel, D; Sommer, N; Stangel, M; Stark, E; Steinbrecher, A; Stoll, G; Toyka, KV; Tumani, H; Voltz, R; Wandinger, KP; Weber, F; Weilbach, F; Weinrich, W; Weissert, R; Wiendl, H; Wietholter, H; Wildemann, B; Zettl, UK; Ziemssen, T; Zipp, F; Zschenderlein, R; Rieckmann, P; Toyka, KV Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)
. 2006; 77(12): 1506-1518. Doi: 10.1007/s00115-006-2220-x
Web of Science PubMed FullText FullText_MUG

 

Korteweg, T; Tintoré, M; Uitdehaag, B; Rovira, A; Frederiksen, J; Miller, D; Fernando, K; Filippi, M; Agosta, F; Rocca, M; Fazekas, F; Enzinger, C; Matthews, P; Parry, A; Polman, C; Montalban, X; Barkhof, F MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study.
LANCET NEUROL. 2006; 5(3): 221-227. Doi: 10.1016/S1474-4422(06)70353-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Rachbauer, D; Kronbichler, M; Ropele, S; Enzinger, C; Fazekas, F Differences in cerebral activation patterns in idiopathic inflammatory demyelination using the paced visual serial addition task: an fMRI study.
J NEUROL SCI. 2006; 244: 11-16. Doi: 10.1016/j.jns.2005.11.035
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum